DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Inflammatory Biomarker Hb/RDW Ratio Predicts AR-DLBCL Outcomes Mar 08, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma 18F-FDG PET/CT Outperforms BMB in DLBCL: Survival Analysis Mar 05, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma PD-L1 Expression in DLBCL for Immunotherapeutic Strategies Feb 27, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma PB-DLBCL With Germinal Centre Origin: EZB Mutational Profile Feb 21, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Glofit + R-CHOP: Efficacy and Safety in DLBCL Feb 13, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Odronextamab Shows High Response Rates in R/R FL Feb 07, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Cuproptosis & Immunogenic Cell Death Model for Diffuse DLBCL Feb 07, 2024
